Trial Profile
Pilot Study of the Effects of LY2409021 in Patients With Type 1 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Adomeglivant (Primary) ; Glucagon
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Eli Lilly and Company
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jul 2012 Actual initiation date (July 2012) and location (USA) added as reported by ClinicalTrials.gov.